28.3.2025 07:00:00 CET | Thor Medical ASA | Annual financial and audit reports

Oslo, 28 March 2025: Thor Medical ASA has today published its annual report, including the
sustanability statement, for the financial year ended 31 December 2024, as well as the Renumeration report for 2024. 

The annual report and remuneration report is available on Thor Medicals's website: www.thormedical.com

This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.

Contacts

• Brede Ellingsæter, CFOO, Thor Medical ASA, +47 472 38 440, brede.ellingseter@thormedical.com

About Thor Medical ASA

Thor Medical is an emerging supplier of radionuclides, primarily alpha particle emitters, from naturally occurring thorium. Its proprietary production process requires no irradiation or use of nuclear reactors, and provides reliable, environmentally friendly, cost-efficient supply of alpha-emitters for the radiopharmaceutical industry. Thor Medical is headquartered in Oslo, Norway and listed on the Oslo Stock Exchange under the ticker symbol ‘TRMED’. 

To learn more, visit  www.thormedical.no.

Attachments

• Download announcement as PDF.pdf
• Thor Medical Annual report 2024.pdf
• thormedicalasa-2024-12-31-0-en.zip
• Thor Medical Remuneration report 2024.pdf